Page last updated: 2024-10-28

hydroxychloroquine and Latent Infection

hydroxychloroquine has been researched along with Latent Infection in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Latent Infection: Delayed infection of the host by a dormant or inactive pathogen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rogado, J1
Gullón, P1
Obispo, B1
Serrano, G1
Lara, MÁ1

Other Studies

1 other study available for hydroxychloroquine and Latent Infection

ArticleYear
Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors.
    European journal of cancer (Oxford, England : 1990), 2021, Volume: 148

    Topics: Adenosine Monophosphate; Aged; Alanine; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; C

2021